Already have an account?

Login with your existing account
New to ESH?

Register today to customize your experience.
Log In
Don't have an account yet? Click here to register

Register for Free
Already have an account? Click here to log in

Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.

Forgot Password

Please Enter your email address.

  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact

Revision date: This policy was last updated on September 30, 2003.

Twitter   facebook

Iron Home > Curriculum > Curriculum 6 > Interactive Poster Sessions from the Annual Meeting, Atlanta, Georgia 2012

Interactive Poster Sessions from the Annual Meeting, Atlanta, Georgia 2012

Begin the Course
Patients with haematologic disorders that result in iron overload, such as transfusion-dependent/non-transfusion-dependent thalassaemia, myelodysplastic syndromes, and sickle cell disease, are at risk for a variety of serious iron-related morbidities, even if they do not receive transfusions. These complications can be reduced or prevented with iron chelation therapy. Three iron chelation agents have been approved throughout the world, and new data on their efficacy and safety continue to emerge. Reports at the 2012 Annual Meeting focused on the use of iron chelation in a variety of indications, providing information that will prove useful in determining the optimal choice of iron chelator, when to initiate treatment for patients with different underlying disorders, and new strategies for improving response.

Learning Objectives

  • Evaluate recent data on iron overload in non–transfusion-dependent thalassaemia (NTDT) patients, on thresholds for the initiation of chelation treatment, and results of deferasirox therapy in order to reduce morbidity and improve outcomes in these patients.
  • Assess recent clinical trial data on the efficacy and safety of iron chelation therapy in NTDT, thalassaemia, sickle cell disease, myelodysplastic syndromes, and acute myeloid leukaemia, including effects on liver iron concentration, cardiac iron, and pituitary volume.


Ali T. Taher, MD
Department of Internal Medicine
American University of Beirut Medical Center
Beirut, Lebanon


Haifa Kathrin Al-Ali, MD
Department of Hematology/Oncology
University of Leipzig
Leipzig, Germany
Emanuele Angelucci, MD
Department Director
Hematology / Medical Oncology
Ospedale Oncologico di Riferimento Regionale “Armando Businco”
Cagliari, Italy
Mohsen Saleh Elalfy, MD
Head of Hematology/Oncology Unit
Pediatric Hemostasis and Thrombosis/Hemoglobinopathy
Ain Shams University
Cairo, Egypt
Amal El Beshlawy, MD, PhD
Pediatric Hematology
Faculty of Medicine
Cairo University
Cairo, Egypt
Hatoon Ezzat, MBBS, FRCPC, ABIM, MSc
Medical Director
Hemoglobinopathy and Hemosiderosis Programs of British Columbia
Department of Medicine
Division of Hematology
University of British Columbia
Vancouver, British Columbia
Lanetta B. Jordan, MD
Associate Professor
University of Miami
Miller School of Medicine
Miami, Florida
Khaled M. Musallam, MD, PhD
Clinical Research Associate
Internal Medicine
Ospedale Maggiore Policlinico
University of Milan
Milan, Italy
Clinical Research Associate
American University of Beirut Medical Center
Beirut, Lebanon
Dudley J. Pennell, MD, FRCP, FACC, FESC
Professor of Cardiology
National Heart and Lung Institute
London, England
Bunchoo Pongtanakul, MD
Faculty of Medicine
Division of Hematology and Oncology
Department of Pediatrics
Siriraj Hospital, Mahidol University
Bangkok, Thailand
Yasser Ahmed Mohammed Wali, MD
Professor and Head, Child Health Department
Sultan Qaboos University
Muscat, Oman
Patrick B. Walter, PhD
Staff Scientist
Children's Hospital & Research Center Oakland
Oakland, California
John C. Wood, MD, PhD
Assistant Professor
Keck School of Medicine of USC
Division of Cardiology
Childrens Hospital Los Angeles
Los Angeles, California
Su-Peng Yeh, MD
Director, Hematology and Oncology
China Medical University
Taichung, Taiwan

Disclosure Information
Haifa Kathrin Al-Ali, MD
has received consulting fees from Novartis Pharmaceuticals Corporation; conducted contracted research for Celgene GmbH; and received honoraria for scientific lectures from Celgene GmbH and Novartis Pharmaceuticals Corporation.
Emanuele Angelucci, MD
has received honoraria from Novartis Pharmaceuticals Corporation.
Mohsen Saleh Elalfy, MD
has disclosed no significant relationships.
Amal El Beshlawy, MD, PhD
is on the speakers bureau of Genzyme and Novartis Pharmaceuticals Corporation.
Hatoon Ezzat, MBBS, FRCPC, ABIM, MSc
has received honoraria from Novartis Pharmaceuticals Corporation.
Lanetta B. Jordan, MD
has served as a consultant for Novartis Pharmaceuticals Corporation.
Khaled M. Musallam, MD, PhD
has received honoraria from Novartis Pharmaceuticals Corporation.
Dudley J. Pennell, MD, FRCP, FACC, FESC
is on the advisory board for Astellas Pharma, Inc. and Novartis Korea.
Bunchoo Pongtanakul, MD
has conducted contracted research for GlaxoSmithKline; and is on the speakers bureau for Novartis Oncology.
Ali T. Taher, MD
is on the speakers bureau of and on the advisory board for Novartis Pharmaceuticals Corporation.
Yasser Ahmed Mohammed Wali, MD
has disclosed no significant relationships.
Patrick B. Walter, PhD
has conducted contracted research for Novartis Pharmaceuticals Corporation.
Dr. Walter has disclosed that his presentation will include a discussion of the off-label use of deferasirox and desferrioxamine combination therapy in transfusion-dependent thalassaemia.
John C. Wood, MD, PhD
has received grant/research support from, is on the speakers bureau of, and is on the advisory board for Novartis Pharmaceuticals Corporation; and is on the advisory board for Apotex Inc.
Su-Peng Yeh, MD
has received consulting fees from Bristol-Myers Squibb.
Begin the Course
This is a Header - close
View All 53 Courses

The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from

ESH-Centre Hayem,
Hospital Saint-Louis
1 avenue Claude Vellefaux.
75475 Paris Cedex 10, France

All Rights Reserved
Copyright ESH 2020